Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometrioid
ovarian cancer patients by glycoproteomic analysis.
Complex atypical hyperplasia (CAH) of the endometrium is considered the precursor for endometrioid
endometrial cancer, the most common gynecologic cancer in the United States.
Cervical adenocarcinomas span a diverse group of tumors with several distinct histologic tumor types, which include endocervical (usual), endometrioid
, intestinal, villoglandular, gastric, signet ring, clear cell, serous, and mesonephric.
Subtypes of endometrial cancer include the more common type I, endometrioid
adenocarcinoma, and the rare type II, which encompasses clear-cell, carcinosarcomas, and endometrial serous carcinoma.
One study conducted by Yasmeen et al shows an endometrioid
carcinoma to be more prevalent as compared to serous one23.
Utility of a novel Serum tumor biomarker HE4 in patients with endometrioid
adenocarcinoma of the uterus.
The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid
and clear cell carcinomas.
In addition, while the FIRES trial included women with high-risk histologies, the majority of patients had low-risk, endometrioid
Concomitant chemoradiation treatment in selected stage I endometrioid
For the two patients who had endometrioid
adenocancer, one of them was stage 1A, and the other was stage 3C.
Paraaortic LN dissection was added to pelvic LN dissection in patients with at least one of the following risk factors: a) non-endometrioid
histology, b) grade 2 or 3 endometrioid
adenocarcinoma, c) deep ([greater than or equal to]50%) myometrial invasion on intraoperative frozen-section examination.
There are numerous literature data to support endometriosis association with endometrioid
and clear cell ovarian carcinoma .